Scleroderma Approved For DOD Funding for FY17
Monday, June 12, 2017
By: Christina Relacion

Thanks to your advocacy efforts, scleroderma remains on the "approved" list for funding as part of the FY2017 Peer-Reviewed Medical Research Program (PRMRP) by the U.S. Department of Defense (DOD).

The funding opportunity announcements for FY2017 have been released by the DOD:

Dept. of the Army -- USAMRAA
DOD Peer Reviewed Medical Discovery Award
Synopsis

Dept. of the Army -- USAMRAA
DOD Peer Reviewed Medical Focused Program Award
Synopsis

Dept. of the Army -- USAMRAA
DOD Peer Reviewed Medical Investigator-Initiated Research Award
Synopsis

Dept. of the Army -- USAMRAA
DOD Peer Reviewed Medical Technology/Therapeutic Development Award
Synopsis